<DOC>
	<DOCNO>NCT02462200</DOCNO>
	<brief_summary>The investigator propose randomize controlled superiority trial standard breast-conserving surgery ( BCS ) versus BCS cavity shave margin ( CSM ) . The main objective trial evaluate prospectively impact routine standardize CSM margin status follow primary surgery early stage breast cancer ( Stage 0 - II ) , post-operative patient satisfaction cosmetic outcome , general intraoperative time operative cost . A parallel group format implement compare modify surgical therapy - BCS CSM - BCS alone , current standard care .</brief_summary>
	<brief_title>Shave Margins Breast Conservation Therapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Newly diagnose , biopsyproven stage 0II breast cancer . Planning undergo breastconserving surgery . At least 18 year age 85 year age . Female . Able understand willing sign IRBapproved write informed consent document . Prior surgical treatment diagnosis . Undergone neoadjuvant chemotherapy . History prior chest radiation therapy . Known metastatic disease . Pregnant . Preference mastectomy instead breastconserving surgery . History ipsilateral breast cancer . Goggle assessment substudy : Iodine seafood allergy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>